|
Nuvation Bio Inc
NUVB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Nuvation Bio Inc growth rates, revenue grew
in IV. Quarter 2024 from the same quarter a year ago.
Ranking at No. 7
Major Pharmaceutical Preparations industry recorded
growth of revenues by 12 %
Nuvation Bio Inc net loss increased from $-14 millions, to $-49 millions in IV. Quarter 2024,
• More on NUVB's Growth
|
|
Nuvation Bio Inc realized a net loss in trailing twelve months.
Nuvation Bio Inc realized cash reduction of $ -0.03 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 67.68.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.
• More on NUVB's Valuation
|
|
|
|
|
Nuvation Bio Inc realized net loss in trailing twelve months.
Nuvation Bio Inc realized cash outflow of $ -0.03per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 67.68.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.41.
Nuvation Bio Inc Price to Book Ratio is at 1.14 lower than Industry Avg. of 91.96. and higher than S&P 500 Avg. of 0.01
• More on NUVB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com